Cargando…

Efficacy of favipiravir in COVID-19 treatment: a multi-center randomized study

No specific antiviral drugs have been approved for the treatment of COVID-19. This study aimed to evaluate the efficacy of favipiravir in treatment of COVID-19. This was a multicenter randomized controlled study including 96 patients with COVID- 19 who were randomly assigned into a chloroquine (CQ)...

Descripción completa

Detalles Bibliográficos
Autores principales:	Dabbous, Hany M., Abd-Elsalam, Sherief, El-Sayed, Manal H., Sherief, Ahmed F., Ebeid, Fatma F. S., El Ghafar, Mohamed Samir Abd, Soliman, Shaimaa, Elbahnasawy, Mohamed, Badawi, Rehab, Tageldin, Mohamed Awad
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer Vienna 2021
Materias:	Brief Report
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7829645/ https://www.ncbi.nlm.nih.gov/pubmed/33492523 http://dx.doi.org/10.1007/s00705-021-04956-9

Ejemplares similares

Retraction Note to: Efficacy of favipiravir in COVID‑19 treatment: a multi‑center randomized study
por: Dabbous, Hany M., et al.
Publicado: (2021)

RETRACTED ARTICLE: Safety and efficacy of favipiravir versus hydroxychloroquine in management of COVID-19: A randomised controlled trial
por: Dabbous, Hany M., et al.
Publicado: (2021)

Retraction Note: Safety and efficacy of favipiravir versus hydroxychloroquine in management of COVID-19: A randomised controlled trial
por: Dabbous, Hany M., et al.
Publicado: (2021)

Response to “Randomized Controlled Trials on COVID-19 Should be Accurate and Trustworthy”
por: Abd-Elsalam, Sherief, et al.
Publicado: (2022)

Remdesivir Efficacy in COVID-19 Treatment: A Randomized Controlled Trial
por: Abd-Elsalam, Sherief, et al.
Publicado: (2022)

Quadruple Therapy Offers High SVR Rates in Patients with HCV Genotype 4 with Previous Treatment Failure
por: Abo-amer, Yousry Esam-Eldin, et al.
Publicado: (2020)

Do Zinc Supplements Enhance the Clinical Efficacy of Hydroxychloroquine?: a Randomized, Multicenter Trial
por: Abd-Elsalam, Sherief, et al.
Publicado: (2020)

Hydroxychloroquine in the Treatment of COVID-19: A Multicenter Randomized Controlled Study
por: Abd-Elsalam, Sherief, et al.
Publicado: (2020)

Efficacy and safety of sofosbuvir–ledipasvir for treatment of a cohort of Egyptian patients with chronic hepatitis C genotype 4 infection
por: Ahmed, Ossama A, et al.
Publicado: (2018)

Metformin ameliorated methotrexate-induced hepatorenal toxicity in rats in addition to its antitumor activity: two birds with one stone
por: Rizk, Fatma H, et al.
Publicado: (2018)

Comparative Evaluation of Colon Cancer Specific Antigen-2 Test and Chromocolonoscopy for Early Detection of Egyptian Patients with Colorectal Cancer
por: Elhossary, Marwa, et al.
Publicado: (2020)

Efficacy and safety of ombitasvir/paritaprevir/ritonavir/ribavirin in management of Egyptian chronic hepatitis C virus patients with chronic kidney disease: A real-life experience
por: Abd-Elsalam, Sherief, et al.
Publicado: (2020)

Pigtail Catheter: A Less Invasive Option for Pleural Drainage in Egyptian Patients with Recurrent Hepatic Hydrothorax
por: Sharaf-Eldin, Mohamed, et al.
Publicado: (2016)

Epidemiology of liver cancer in Nile delta over a decade: A single-center study
por: Abd-Elsalam, Sherief, et al.
Publicado: (2018)

A novel scoring system for prediction of esophageal varices in critically ill patients
por: Hanafy, Amr Shaaban, et al.
Publicado: (2017)

Challenges in COVID-19 drug treatment in patients with advanced liver diseases: A hepatology perspective
por: Hanafy, Amr Shaaban, et al.
Publicado: (2020)

IL-1α correlates with severity of hepatitis C virus-related liver diseases
por: Tawfik, Ahmed Khaled, et al.
Publicado: (2018)

Endoscopic injection sclerotherapy versus N-Butyl-2 Cyanoacrylate injection in the management of actively bleeding esophageal varices: a randomized controlled trial
por: Elsebaey, Mohamed A., et al.
Publicado: (2019)

Persistent Colonic Schistosomiasis among Symptomatic Rural Inhabitants in the Egyptian Nile Delta
por: Ahmed, Mohamed Hussien, et al.
Publicado: (2021)

A 2-week Nitazoxanide-based quadruple treatment as a rescue therapy for Helicobacter pylori eradication: A single center experience
por: Abd-Elsalam, Sherief, et al.
Publicado: (2016)

Impact of Helicobacter pylori Infection on Gastric Variceal Bleeding among Patients with Liver Cirrhosis
por: Elsebaey, Mohamed A., et al.
Publicado: (2019)

Adherence to the Mediterranean Diet Improved Clinical Scores and Inflammatory Markers in Children with Active Inflammatory Bowel Disease: A Randomized Trial
por: El Amrousy, Doaa, et al.
Publicado: (2022)

Assessment of CXCL10 Before and After Narrow Band UVB Phototherapy in Non-Segmental Vitiligo Patients
por: Hussein, Sherief M., et al.
Publicado: (2022)

Predictors for eltrombopag response in patients with hepatitis C virus-associated thrombocytopenia
por: Elbedewy, Tamer A, et al.
Publicado: (2019)

Randomized Controlled Study Comparing Use of Propofol Plus Fentanyl versus Midazolam Plus Fentanyl as Sedation in Diagnostic Endoscopy in Patients with Advanced Liver Disease
por: Ahmed, Sameh Abdelkhalik, et al.
Publicado: (2017)

Amyloid A in Serum and Ascitic Fluid as a Novel Diagnostic Marker of Spontaneous Bacterial Peritonitis
por: Badawi, Rehab, et al.
Publicado: (2020)

Evaluation of portal pressure by doppler ultrasound in patients with cirrhosis before and after simvastatin administration – a randomized controlled trial
por: Elwan, Nadia, et al.
Publicado: (2018)

Outcomes and predictors of treatment response with sofosbuvir plus daclatasvir with or without ribavirin in Egyptian patients with genotype 4 hepatitis C virus infection
por: Ahmed, Ossama A, et al.
Publicado: (2018)

Pro-Neurotensin as a Potential Novel Diagnostic Biomarker for Detection of Nonalcoholic Fatty Liver Disease
por: Mohamed, Amal A, et al.
Publicado: (2022)

Correlation of platelets count with endoscopic findings in a cohort of Egyptian patients with liver cirrhosis
por: Abd-Elsalam, Sherief, et al.
Publicado: (2016)

Hypervascular Nodules and Stiffer Liver are Associated with Recurrence after Microwave Ablation in Patients with Hepatocellular Carcinoma: A Double-Center Analysis
por: Shehata, Mona A. H., et al.
Publicado: (2020)

Helicobacter pylori may be an initiating factor in newly diagnosed ulcerative colitis patients: A pilot study
por: Mansour, Loai, et al.
Publicado: (2018)

Sofosbuvir Plus Daclatasvir in Treatment of Chronic Hepatitis C Genotype 4 Infection in a Cohort of Egyptian Patients: An Experiment the Size of Egyptian Village
por: Ahmed, Ossama Ashraf, et al.
Publicado: (2018)

Safety, Efficacy, and Tolerability of Sofosbuvir and Ribavirin in Management of Recurrent Hepatitis C Virus Genotype 4 After Living Donor Liver Transplant in Egypt: What Have We Learned so far?
por: Dabbous, Hany M., et al.
Publicado: (2016)

Effect of Two Different Rehabilitation Approaches on Pulmonary Functional Tests, Neuromuscular Functions and Quality of Life in Juvenile Myasthenia Gravis: A Randomized Controlled Trial Study
por: Mohamed, Rasha A., et al.
Publicado: (2022)

Management of liver disease patients in different clinical situations during COVID-19 pandemic
por: Zaky, Samy, et al.
Publicado: (2021)

Norepinephrine is More Effective Than Midodrine/Octreotide in Patients With Hepatorenal Syndrome-Acute Kidney Injury: A Randomized Controlled Trial
por: El-Desoki Mahmoud, Eman Ibrahim, et al.
Publicado: (2021)

Serum Dickopff 1 as a Novel Biomarker in Hepatocellular Carcinoma Diagnosis and Follow Up After Ablative Therapy
por: Younis, Yehia Sadek, et al.
Publicado: (2019)

Multifocal fatty liver disease, insulin resistance and carotid atherosclerosis: exploring the interrelated relationship
por: Hanafy, Amr Shaaban, et al.
Publicado: (2018)

Copeptin as a novel marker predicting prognosis of liver cirrhosis and its major complications
por: Tawfik, Ahmed Khaled, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_31dt78e9vb1c1rplluml6a8lli